SCHEMBL22804232

SCHEMBL22804232

O=[N+]([O-])c1ccc2c(c1Br)OCCO2

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TXNRD1 Q16881 1/20 0.50
TXNRD3 Q86VQ6 1/20 0.50
TXNRD2 Q9NNW7 1/20 0.50
MAPT P10636 10/20 0.45
ALDH1A1 P00352 7/20 0.39
RAB9A P51151 6/20 0.39
NPC1 O15118 5/20 0.39
HTT P42858 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.36
LMNA P02545 2/20 0.36
MEN1 O00255 5/20 0.36
KMT2A Q03164 5/20 0.36
MAPK1 P28482 4/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
RECQL P46063 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6619488 0.86 TXNRD1 (0.68) TXNRD1TXNRD3TXNRD2MAPTALDH1A1
SCHEMBL30414974 0.86 TXNRD1 (0.68) TXNRD1TXNRD3TXNRD2MAPTALDH1A1
SCHEMBL13015521 0.81 TXNRD1 (0.75) TXNRD1TXNRD3TXNRD2MAPTALDH1A1
SCHEMBL17099743 0.79 TXNRD1 (0.50) TXNRD1TXNRD3TXNRD2MAPTALDH1A1
SCHEMBL8403306 0.79 TXNRD1 (0.50) TXNRD1TXNRD3TXNRD2MAPTALDH1A1
SCHEMBL30329884 0.76 CYP1A2 (0.51) TXNRD1TXNRD3TXNRD2MAPTALDH1A1
SCHEMBL11262989 0.76 TXNRD1 (0.46) TXNRD1TXNRD3TXNRD2MAPTALDH1A1
SCHEMBL30329662 0.76 MAPT (0.49) TXNRD1TXNRD3TXNRD2MAPTALDH1A1
SCHEMBL30329969 0.76 MAPT (0.49) TXNRD1TXNRD3TXNRD2MAPTALDH1A1
SCHEMBL13015522 0.76 TXNRD1 (0.46) TXNRD1TXNRD3TXNRD2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112469713-B Aryl phosphorus oxide derivative inhibitor, preparation method and application thereof 江苏豪森药业集团有限公司 2023-09-01 CN disclosed
CN-116234556-A Crystal form of aryl phosphorus oxide derivative free alkali and preparation method and application thereof 江苏豪森药业集团有限公司 2023-06-06 CN disclosed
WO-2023011610-A1 BENZODIOXANE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 南京红云生物科技有限公司 2023-02-09 WO disclosed
WO-2022127807-A1 CRYSTAL FORM OF ARYL PHOSPHORUS OXIDE DERIVATIVE FREE BASE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF 江苏豪森药业集团有限公司 2022-06-23 WO disclosed
WO-2022127807-A1 CRYSTAL FORM OF ARYL PHOSPHORUS OXIDE DERIVATIVE FREE BASE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF 江苏豪森药业集团有限公司 2022-06-23 WO disclosed
CN-114644654-A Oxidized aryl phosphorus derivative, acid salt or crystal form thereof, and preparation method and application thereof 上海翰森生物医药科技有限公司 2022-06-21 CN disclosed
CN-112469713-A Aryl phosphorus oxide derivative inhibitor, preparation method and application thereof 江苏豪森药业集团有限公司 2021-03-09 CN disclosed
WO-2020253860-A1 ARYL PHOSPHORUS OXIDE DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF 江苏豪森药业集团有限公司 2020-12-24 WO disclosed
WO-2020253860-A1 ARYL PHOSPHORUS OXIDE DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF 江苏豪森药业集团有限公司 2020-12-24 WO disclosed